Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 07:32 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Low-dose HCG as an Adjunct to Ovarian Stimulation in Subfertile Women Undergoing ART
NCT03423537 · National and Kapodistrian University of Athens · PHASE3 · terminated · last registry update 2021-03-30 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Inability for further recruitment, change of position of the principal investigator, COVID-19 pandemic” | – | Registry record, National and Kapodistrian University of Athens |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against LHCGR within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2022-02-17Results posted on the registry: El Shatby University Hospital for Obstetrics and Gynecology, Duphaston + Gonadotropin (NCT04537078)
- 2022-02-03Also stopped (withdrawn): Organon and Co, MK-8962 + recFSH (NCT01599494)
- 2022-01-28Also stopped (terminated): Reproductive Medicine Associates of New Jersey, a drug against LHCGR (NCT04852029)
- 2022-01-11Also stopped (withdrawn): Reproductive & Genetic Hospital of CITIC-Xiangya, intrauterine injection of HCG (NCT02870855)
- 2021-05-10Also stopped (terminated): Universitaire Ziekenhuizen KU Leuven, a drug against LHCGR (NCT03790449)
- 2021-05-03Phase 3 first posted: Saudi German Hospital - Madinah, Controlled ovarian stimulation by Combined Clomiphene Citrate and Ubiquinol Versus hMG (NCT04870502)
- 2021-04-08Results posted on the registry: Organon and Co, Corifollitropin alfa + hCG (NCT03019575)
- 2021-01-25Results posted on the registry: Fox Chase Cancer Center, recombinant human chorionic gonadotropin + microarray analysis (NCT00700778)
- 2021-01-25Also stopped (terminated): Fox Chase Cancer Center, recombinant human chorionic gonadotropin + microarray analysis (NCT00700778)
- 2020-09-16Phase 3 first posted: JHSPH Center for Clinical Trials, a drug against LHCGR (NCT04551807)
- 2020-09-03Phase 3 first posted: El Shatby University Hospital for Obstetrics and Gynecology, Duphaston + Gonadotropin (NCT04537078)
- 2020-07-07Results posted on the registry: Weill Medical College of Cornell University, Letrozole + Letrozole (NCT01035099)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision